Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | 08-2011 | 12-2010 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | N/A | -1,561 | -600 | N/A |
| Depreciation Amortization | 6 | 28 | 8 | N/A |
| Other Working Capital | -60 | -67 | -180 | N/A |
| Other Operating Activity | 70 | -106 | 283 | 0 |
| Operating Cash Flow | $16 | $-1,706 | $-490 | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | N/A | -1,700 | N/A | N/A |
| PPE Investments | 0 | -2 | 0 | N/A |
| Other Investing Activity | 450 | -1 | 100 | 0 |
| Investing Cash Flow | $450 | $-1,703 | $100 | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | N/A | 3,694 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 300 | 0 |
| Financing Cash Flow | $N/A | $3,694 | $300 | $N/A |
| Exchange Rate Effect | N/A | 29 | 0 | N/A |
| Beginning Cash Position | N/A | 1,200 | 1,190 | N/A |
| End Cash Position | N/A | 1,513 | 1,100 | N/A |
| Net Cash Flow | $466 | $314 | $-90 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | 16 | -1,706 | -490 | N/A |
| Capital Expenditure | N/A | -2 | N/A | N/A |
| Free Cash Flow | 16 | -1,708 | -490 | 0 |